1. 1112PD_PRReal-world productivity, healthcare resource utilization (HRU), and quality of life (QOL) in patients with advanced gastric cancer (GC) in Canada and Europe. (18th September 2017) Authors: Maglinte, G.; Rider, A.; Contente, M.; Boyers, A.; Clarke, B.; Calvo, E. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with advanced cancer: Update of initial phase I results. (December 2022) Authors: Simonelli, M.; Calvo, E.; Davar, D.; Richards, D.; Gutierrez, M.; Moreno Garcia, V.; Marron, T.; Rottey, S.; Orcurto, A.; Renouf, D.J.; Joerger, M.; Barriga Falcon, S.; Fan, J.; Gibson, E.; Chakraborty, D.; Arora, V.; Melero, I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 28LBA A phase 1 study of PF-06647020, an antibody-drug conjugate targeting PTK7, in patients with advanced solid tumors. (September 2015) Authors: Tolcher, A.W.; Calvo, E.; Maitland, M.L.; Gibson, B.; Xuan, D.; Joh, T.; Jackson-Fischer, A.; Damelin, M.; Barton, J.; Xin, X.; Sachdev, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC). (September 2015) Authors: Calvo, E.; López-Martin, J.A.; Bendell, J.; Eder, J.P.; Taylor, M.; Ott, P.A.; Pietanza, M.C.; Horn, L.; Jäger, D.; Braud, F. De; Morse, M.A.; Ascierto, P.A.; Le, D.T.; Amin, A.; Evans, J.; Simon, J.; Lin, C.S.; Christensen, O.; Antonia, S.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 335 Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors. (September 2015) Authors: Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; Varghese, A.M.; Jimenez, E.; Luque, J.; Soto-Matos, A.; Szyldergemajn, S.; Sessa, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 361 Phase I, open-label, dose-escalating clinical and pharmacokinetic study of the novel antimicrotubulin agent PM060184 administered over 10 minutes on days 1-3 and 15-17 every 28 days to patients with advanced malignant solid tumors. (September 2015) Authors: Hidalgo, M.; Boni, V.; Tolcher, A.; Smith, L.; Cubillo, A.; Rasco, D.; Calvo, E.; Amaya, A.; Ordoñez, E.; Patnaik, A.; Cerda, S.; Coronado, C.; Fudio, S.; Miguel-Lillo, B.; Prados, R.; Ortega, O.; Soto-Matos, A.; Papadopoulos, K.P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A 4 tonne demonstrator for large-scale dual-phase liquid argon time projection chambers. (6th November 2018) Authors: Aimard, B.; Alt, Ch.; Asaadi, J.; Auger, M.; Aushev, V.; Autiero, D.; Badoi, M.M.; Balaceanu, A.; Balik, G.; Balleyguier, L.; Bechetoille, E.; Belver, D.; Blebea-Apostu, A.M.; Bolognesi, S.; Bordoni, S.; Bourgeois, N.; Bourguille, B.; Bremer, J.; Brown, G.; Brunetti, G. Journal: Journal of instrumentation Issue: Volume 13:Number 11(2018:Nov.) Page Start: P11003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A light calibration system for the ProtoDUNE-DP detector. (1st April 2019) Authors: Belver, D.; Boix, J.; Calvo, E.; Cuesta, C.; Gallego-Ros, A.; Gil-Botella, I.; Jiménez, S.; Lastoria, C.; Lux, T.; Martín, I.; Martínez, J.J.; Palomares, C.; Redondo, D.; Soto-Oton, J.; Vargas, D.; Verdugo, A. Journal: Journal of instrumentation Issue: Volume 14:Number 4(2019) Page Start: T04001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients. (December 2021) Authors: Le Tourneau, C.; Calugaru, V.; Moreno, V.; Calvo, E.; Liem, X.; Salas, S.; Doger, B.; Jouffroy, T.; Mirabel, X.; Rodriguez, J.; Chilles, A.; Bernois, K.; Fakhry, N.; Wong Hee Kam, S.; Hoffmann, C. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0106 The Small Gtpase Rhoa Signalling is Upregulated in the Cartilage of Patients with Knee Osteoarthritis Through the Phosphorylation of Myosin Light-Chain (MLC) Phosphatase Regulatory Unit MYPT-1 Induced by ERK: In Vivo and in Vitro Studies. (9th June 2015) Authors: Pérez-Baos, S.; Andrés-Bergόs, J.; Barrasa, J.I.; Larrañaga-Vera, A.; Calvo, E.; Sanz-Gomez, P.; Sánchez-Biezma, E.; Herrero-Beaumont, G.; Largo, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗